Drugs / Towne CMV Vaccine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00370006 | Sep 2006 → Aug 2007 | cytomegalovirus infection | University of California, San Francisco | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00201448 | Jun 2007 → Oct 2009 | cytomegalovirus infection | Virginia Commonwealth University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Towne CMV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00370006 ↗ |
| Modality | Vaccine | “the live attenuated Towne CMV vaccine” NCT00201448 ↗ |
| Route | Subcutaneous | “Single dose given subcutaneously” NCT00201448 ↗ |